logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Richard B. Warren

Manchester Academic Health Science Centre

69H指数
700论文数
1.7W被引数
收录论文 344
发表时间
logo
Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial基于ARCAＤIA 1期3临床试验数据开发特应性皮炎的概念性疾病模型
errDermatology and Therapy
IF4.2
err2026-09-22
err0
errOAAI
errJonathan I. Silverberg; Patrick Daniele; Danielle Rodriguez; Sarah Mulnick; Gil Yosipovitch; Lawrence F. Eichenfield; Melinda Gooderham; Richard Warren; Ramkumar Subramanian; Katrin Jack; Liliana Ulianov; Christophe Piketty; Rajesh Rout; Jorge Puelles
err分享
err收藏
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials德卡鲁昔替尼治疗斑块状银屑病5年安全性和有效性结果：一项随机临床试验的III期开放标签扩展研究
errAmerican Journal of Clinical Dermatology
IF8.8
err2026-08-07
err0
errOAAI
errApril W. Armstrong; Mark Lebwohl; Richard B. Warren; Akimichi Morita; Carle Paul; Diamant Thaçi; Matthias Augustin; Lluís Puig; Carolin Daamen; Janice Li; Alessandra Alió; Angela Aggrey-Amable; Julie Scotto; Zoran Popmihajlov; John Vaile; Bruce Strober
err分享
err收藏
Cost-Utility Analyses of Systemic Treatments for Psoriasis and Psoriatic Arthritis in the UK: A Systematic Review of Modelling Methods英国银屑病和银屑病关节炎全身治疗方案的经济学评价：建模方法的系统综述
errPharmacoeconomics
IF4.6
err2026-07-08
err0
PREAI
errThomas S. Clemmet; Duc Binh Phan; Alice Copson; Richard B. Warren; Zenas Z. N. Yiu; Gabriel Rogers
err分享
err收藏
Serious infection risk with systemic treatments for psoriasis: A cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)银屑病系统性治疗中的严重感染风险：英国皮肤科医师生物制剂干预登记研究（BADBIR）队列研究
errBritish Journal of Dermatology
IF9.6
err2026-05-05
err0
PREAI
errHeber Rew Bright Bright; Catherine H Smith; Philip Laws; Nick J Reynolds; Duc Binh Phan; Mark Lunt; Richard B Warren; Zenas Z N Yiu
err分享
err收藏
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study评价阿达木单抗在银屑病中的治疗药物监测策略：一项前瞻性药代动力学-药效学研究
errClinical and Translational Science
IF2.8
err2026-04-30
err0
errOAAI
errShan Pan; Teresa Tsakok; Ruoheng Wei; Nick Dand; Floris C. Loeff; Karien Bloem; Annick de Vries; David Baudry; Michael Duckworth; Angela Pushpa-Rajah; Alice Russell; Ali Alsharqi; Gabrielle Becher; Ruth Murphy; Shyamal Wahie; Andrew Wright; Christopher E. M. Griffiths; Nick J. Reynolds; Jonathan Barker; Richard B. Warren; A. David Burden; Theo Rispens; Satveer K. Mahil; Joseph F. Standing; Catherine H. Smith; the BADBIR Study Group; the BSTOP Study Group and the PSORT Consortium
err分享
err收藏
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND特应性皮炎中度至重度患者接受特立珠单抗治疗长达6年的长期安全性与有效性：开放标签扩展试验ECZTEND的最终结果
errDermatology and Therapy
IF4.2
err2026-02-05
err0
errOAAI
errAndrew Blauvelt; H. Chih-Ho Hong; Norito Katoh; Richard G. Langley; Vivian Laquer; Aleksandra Lesiak; Ketty Peris; Julien Seneschal; Juan-Francisco Silvestre; Richard B. Warren; Andreas Wollenberg; Matthew Zirwas; Niels Højsager Bennike; Farzaneh Safavimanesh; Ann-Marie Tindberg; Kristian Reich
err分享
err收藏
Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 YearBimekizumab治疗具有显著皮肤和指甲银屑病症状的银屑病关节炎患者的疗效与安全性（随访1年）
errDermatology and Therapy
IF4.2
err2025-12-12
err0
errOAAI
errDiamant Thaçi; Akihiko Asahina; Wolf-Henning Boehncke; Alice B. Gottlieb; Mark Lebwohl; Richard B. Warren; Heather Edens; Barbara Ink; Rajan Bajracharya; Jason Coarse; Joseph F. Merola
err分享
err收藏
Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary CentreLebrikizumab治疗中重度特应性湿疹：来自三级中心的真实世界经验
errDermatology and Therapy
IF4.2
err2025-12-06
err0
errOAAI
errAzmeralda Abraheem; Neenu Sebastian; Firas C. Kreeshan; Tim H. Clayton; Hamish J. A. Hunter; Richard B. Warren
err分享
err收藏
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis德卡鲁赞替尼在斑块状银屑病中的应用：继阿普米司特治疗反应不足后的第3期POETYK分析
errDermatology and Therapy
IF4.2
err2025-12-05
err0
errOAAI
errApril W. Armstrong; Richard B. Warren; Howard Sofen; Lynda Spelman; Misti Linaberry; Brandon Becker; Ying-Ming Jou; Carolin Daamen; Alexa B. Kimball
err分享
err收藏
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals慢性累积性生命历程损伤是否被纳入银屑病管理？——一项针对银屑病患者和医疗保健专业人士的多国调查
errDermatology and Therapy
IF4.2
err2025-11-22
err0
errOAAI
errRaymond Matthews; April W. Armstrong; Matthias Augustin; Christopher Baker; José Manuel Carrascosa; Brian Kirby; Richard Langley; Sandy McBride; Adam Reich; Ricardo Romiti; Francesca Sampogna; Richard B. Warren
err分享
err收藏
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
errNEJM Evidence
IF0
err2025-11-01
err3
PREAI
errGooderham, Melinda; Lain, Edward; Bissonnette, Robert; Huang, Yu-Huei; Lynde, Charles W.; Hoffmann, Matthias; Song, Eingun James; Weirich, Oliver; Ceitlin, Raul Hernan Gabriel; Rubens, Jessica H.; Delozier, Amy M.; Ota, Takayuki; Hsu, Ming-Chun; Li, Shu; Deklotz, Cynthia M. C.; Nunes, Fabio; Warren, Richard B.
err分享
err收藏
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials特应性皮炎患者中特立洛金单抗的安全性（随访长达4.5年）：一项八项临床试验的整合分析
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-11-01
err1
errOAAI
errReich, Kristian; Langley, Richard G.; Silvestre Salvador, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew E.; Paller, Amy S.; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Blauvelt, Andrew; Bjerregard Oland, Christian; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric L.
err分享
err收藏
Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical TrialsBimekizumab在银屑病中的疗效：基于3期/3b期临床试验的亚组后分析
errDermatology and Therapy
IF4.2
err2025-10-08
err0
errOAAI
errBruce Strober; Wolf-Henning Boehncke; James G. Krueger; Nina Magnolo; Ronald Vender; Richard B. Warren; José Manuel López Pinto; Sarah Kavanagh; Bengt Hoepken; Paolo Gisondi
err分享
err收藏
Serious Infection Risk with Systemic Treatments for Psoriasis: A Systematic Review and Network Meta-analysis Combining Randomised and Non-randomised Evidence银屑病系统性治疗中的严重感染风险：一项结合随机和非随机证据的系统评价与网络meta分析
errDERMATOLOGY AND THERAPY
IF4.2
err2025-10-01
err0
errOAAI
errBright, Heber Rew Bright; Phan, Duc Binh; Zahid, Amna; Aval, Leila Motedayen; Manupati, Shilpa; Smith, Catherine H.; Exton, Lesley S.; Ezejimofor, Martinsixtus; Lunt, Mark; Warren, Richard B.; Yiu, Zenas Z. N.
err分享
err收藏
Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis奥利司他酯（Orismilast），一种强效且选择性的PDE4B/D抑制剂，可降低斑块状银屑病患者皮肤中关键疾病驱动细胞因子的蛋白水平。
errEXPERIMENTAL DERMATOLOGY
IF3.1
err2025-09-19
err0
errOAAI
errWarren, Richard B.; Weiss, Anne; Felding, Jakob; Sommer, Morten O. A.; Garcet, Sandra; Krueger, James G.
err分享
err收藏
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage)Lebrikizumab在成人及青少年患者中治疗中重度特应性皮炎的疗效与安全性：一项安慰剂对照、随机IIIb期临床试验（ADvantage）
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-09-01
err1
PREAI
errWarren, Richard B.; de Bruin-Weller, Marjolein; Tsianakas, Athanasios; Khemis, Abdallah; Szepietowski, Jacek C.; Hong, H. Chih-ho; Mihaylov, Yanislav; Falques, Meritxell; Agell, Helena; Massana, Eric; Gil, Esther Garcia; Coll, Ruth; Weidinger, Stephan
err分享
err收藏
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb StudiesBimekizumab对皮肤和指甲银屑病均实现完全清除：III/IIIb期研究的比较疗效
errAmerican Journal of Clinical Dermatology
IF8.8
err2025-08-31
err0
errOAAI
errJoseph F. Merola; Richard B. Warren; Diamant Thaçi; Kenneth B. Gordon; Emi Nishida; Bruce Strober; Curdin Conrad; Sarah Kavanagh; José Manuel López Pinto; Bengt Hoepken; Paolo Gisondi
err分享
err收藏
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis孟德尔随机化研究确定OX40是吸烟对掌跖脓疱病影响的潜在中介因素。
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-08-01
err0
errOAAI
errSmail, Alice; Dand, Nick; Liu, Xinyue; Burden, A. David; Baudry, David; Griffiths, Christopher E. M.; Pink, Andrew; Reynolds, Nick J.; Warren, Richard B.; Barker, Jonathan N.; Smith, Catherine H.; Capon, Francesca
err分享
err收藏
Predictors of differential treatment response between adalimumab and methotrexate in psoriasis: a causal forest analysis of the British Association of Dermatologists Biologics and Immunomodulators Register银屑病患者adalimumab与甲氨蝶呤差异化治疗反应的预测因子：英国皮肤科医生学会生物制剂和免疫调节剂登记研究的因果森林分析
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-07-01
err0
errOAAI
errHaw, William W. Y.; Alabas, Oras A.; Sperrin, Matthew; Cina, Giovanni; Abu-Hanna, Ameen; Warren, Richard B.
err分享
err收藏
(P002) Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data(P002) 预测银屑病生物制剂药物停用：一种基于英国皮肤科医师学会生物制剂和免疫调节剂登记数据的可解释机器学习方法
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-07-01
err0
errOAAI
errHussain, Amaani B.; Iqbal, Wasim; Atallah, Christian; Warren, Richard B.; Barnes, Michael; Missier, Paolo; Reynolds, Nick J.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Mark I. McCarthy
H 指数: 222 · 论文数: 1.5K
P
Panos Deloukas
H 指数: 197 · 论文数: 764
C
Christian Gieger
H 指数: 175 · 论文数: 942
T
Tōnu Esko
H 指数: 165 · 论文数: 826
R
Robert Plomin
H 指数: 162 · 论文数: 1.5K
查看更多